000			01827 a2200481 4500
005			20250517003705.0
264		0	_c20150527
008			201505s 0 0 eng d
022			_a1471-2415
024	7		_a10.1186/1471-2415-14-151 _2doi
040			_aNLM _beng _cNLM
100	1		_aDuBiner, Harvey B
245	0	0	_aLate-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial. _h[electronic resource]
260			_bBMC ophthalmology _cNov 2014
300			_a151 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmides _xadverse effects
650	0	4	_aAntihypertensive Agents _xadverse effects
650	0	4	_aBenzalkonium Compounds _xadverse effects
650	0	4	_aBimatoprost
650	0	4	_aCloprostenol _xadverse effects
650	0	4	_aCross-Over Studies
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aGlaucoma, Open-Angle _xdrug therapy
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOcular Hypertension _xdrug therapy
650	0	4	_aOphthalmic Solutions
650	0	4	_aPreservatives, Pharmaceutical _xadverse effects
650	0	4	_aProspective Studies
650	0	4	_aTherapeutic Equivalency
650	0	4	_aTonometry, Ocular
650	0	4	_aTravoprost
700	1		_aHubatsch, Douglas A
773	0		_tBMC ophthalmology _gvol. 14 _gp. 151
856	4	0	_uhttps://doi.org/10.1186/1471-2415-14-151 _zAvailable from publisher's website
999			_c24387382 _d24387382